Research Focus

Research and Technology Management; Clinical Research Manager

Recent additions – View all

1. Phase III multi-center, prospective randomized trial comparing high dose single fraction radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic human cancer

   Meeting Abstract

   Zelefsky, M. J.; Yamada, Y.; Lis, E.; Schoder, H.; Lochansingh, S.; Shi, W.; Zhigang, Z.; Braunstein, S. E.; Kolesnick, R.; Fuks, Z.
   International Journal of Radiation Oncology, Biology, Physics (2018)

   Fulltext@MSK | Save
2. A phase I trial of dose-escalated image-guided, intensity modulated radiation therapy in combination with concurrent gemcitabine chemotherapy for node-negative, muscle-invasive bladder cancer (MIBC)

   Meeting Abstract

   Kollmeier, M. A.; Zelefsky, M. J.; McBride, S.; Debonis, D.; Lochansingh, S.; Varghese, M.; Bochner, B.; Rosenberg, J.; Bajorin, D.
   International Journal of Radiation Oncology, Biology, Physics (2018)

   Fulltext@MSK | Save
3. A phase II trial of low dose rate brachytherapy combined with ultra-hypofractionated, image-guided, intensity-modulated radiation therapy for clinically localized, intermediate risk prostate cancer: A preliminary analysis

   Meeting Abstract

   Kollmeier, M. A.; McBride, S.; Lochansingh, S.; Varghese, M.; Debonis, D.; Cohen, G.; Damato, A. L.; Zelefsky, M. J.
   International Journal of Radiation Oncology, Biology, Physics (2018)

   Fulltext@MSK | Save